Applied DNA Sciences Inc (APDN)
4.06
+0.04
(+1.00%)
USD |
NASDAQ |
May 02, 16:00
4.06
0.00 (0.00%)
After-Hours: 17:04
Applied DNA Sciences Cash from Operations (TTM): -7.592M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -7.592M |
September 30, 2023 | -6.218M |
June 30, 2023 | -6.796M |
March 31, 2023 | -7.182M |
December 31, 2022 | -7.658M |
September 30, 2022 | -8.977M |
June 30, 2022 | -10.43M |
March 31, 2022 | -9.926M |
December 31, 2021 | -12.93M |
September 30, 2021 | -13.39M |
June 30, 2021 | -11.66M |
March 31, 2021 | -13.42M |
December 31, 2020 | -12.57M |
September 30, 2020 | -11.14M |
June 30, 2020 | -9.937M |
March 31, 2020 | -8.211M |
December 31, 2019 | -8.079M |
September 30, 2019 | -6.862M |
June 30, 2019 | -7.594M |
March 31, 2019 | -7.440M |
December 31, 2018 | -5.858M |
September 30, 2018 | -6.917M |
June 30, 2018 | -5.322M |
March 31, 2018 | -6.060M |
December 31, 2017 | -7.983M |
Date | Value |
---|---|
September 30, 2017 | -7.479M |
June 30, 2017 | -9.012M |
March 31, 2017 | -9.372M |
December 31, 2016 | -9.245M |
September 30, 2016 | -9.897M |
June 30, 2016 | -9.189M |
March 31, 2016 | -8.218M |
December 31, 2015 | -7.331M |
September 30, 2015 | -6.966M |
June 30, 2015 | -7.468M |
March 31, 2015 | -8.222M |
December 31, 2014 | -8.802M |
September 30, 2014 | -8.513M |
June 30, 2014 | -8.444M |
March 31, 2014 | -8.244M |
December 31, 2013 | -8.196M |
September 30, 2013 | -7.870M |
June 30, 2013 | -6.690M |
March 31, 2013 | -6.006M |
December 31, 2012 | -4.890M |
September 30, 2012 | -3.961M |
June 30, 2012 | -4.529M |
March 31, 2012 | -4.115M |
December 31, 2011 | -4.103M |
September 30, 2011 | -3.762M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-13.42M
Minimum
Mar 2021
-6.218M
Maximum
Sep 2023
-9.504M
Average
-8.977M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Fonar Corp | 15.29M |
XWELL Inc | -16.07M |
ProPhase Labs Inc | -11.35M |
Veracyte Inc | 44.22M |
OncoCyte Corp | -23.32M |